Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate.

Kaygusuz Atagunduz, Isik; Toptas, Tayfur; Deniz, Rabia; Kara, Osman; Eser, Ali; Sezgin, Aslihan; Ozgumus, Toluy; Gecgel, Fatma; Firatli Tuglular, Tulin

Kaygusuz Atagunduz, Isik; Toptas, Tayfur; Deniz, Rabia; Kara, Osman; Eser, Ali; Sezgin, Aslihan; Ozgumus, Toluy; Gecgel, Fatma; Firatli Tuglular, Tulin.

Afiliación

Kaygusuz Atagunduz I; Department of Hematology, Marmara University Hospital, Istanbul, Turkey. Electronic address: isikkaygusuz@yahoo.com.
Toptas T; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Deniz R; Department of Internal Medicine, Marmara University Hospital, Istanbul, Turkey.
Kara O; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Eser A; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Sezgin A; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Ozgumus T; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Gecgel F; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Firatli Tuglular T; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.

Clin Lymphoma Myeloma Leuk ; 17(2): 120-125, 2017 02.

Article en En | MEDLINE | ID: mdl-28082113

Asunto(s)

Antineoplásicos/uso terapéutico; Mesilato de Imatinib/uso terapéutico; Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico; Adolescente; Adulto; Anciano; Anciano de 80 o más Años; Citogenética/métodos; Supervivencia sin Enfermedad; Femenino; Proteínas de Fusión bcr-abl/metabolismo; Humanos; Leucemia Mielógena Crónica BCR-ABL Positiva/metabolismo; Leucemia Mielógena Crónica BCR-ABL Positiva/mortalidad; Masculino; Persona de Mediana Edad; Pronóstico; Estudios Retrospectivos; Adulto Joven

Palabras clave

BCR-ABL; Disease outcome; Molecular monitorization; Progression-free survival; Tyrosine kinase inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google